GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Laboratories Ltd (BOM:539287) » Definitions » Enterprise Value

Ortin Laboratories (BOM:539287) Enterprise Value : ₹206.04 Mil (As of May. 25, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Ortin Laboratories Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ortin Laboratories's Enterprise Value is ₹206.04 Mil. Ortin Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-36.34 Mil. Therefore, Ortin Laboratories's EV-to-EBIT ratio for today is -5.67.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ortin Laboratories's Enterprise Value is ₹206.04 Mil. Ortin Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-34.22 Mil. Therefore, Ortin Laboratories's EV-to-EBITDA ratio for today is -6.02.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ortin Laboratories's Enterprise Value is ₹206.04 Mil. Ortin Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹34.23 Mil. Therefore, Ortin Laboratories's EV-to-Revenue ratio for today is 6.02.


Ortin Laboratories Enterprise Value Historical Data

The historical data trend for Ortin Laboratories's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Laboratories Enterprise Value Chart

Ortin Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 391.92 292.29 331.40 240.29 203.67

Ortin Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 192.71 203.67 185.23 215.15 187.18

Competitive Comparison of Ortin Laboratories's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Laboratories's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortin Laboratories's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Laboratories's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Ortin Laboratories's Enterprise Value falls into.



Ortin Laboratories Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Ortin Laboratories's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as

Ortin Laboratories's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ortin Laboratories  (BOM:539287) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Ortin Laboratories's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=206.038/-36.338
=-5.67

Ortin Laboratories's current Enterprise Value is ₹206.04 Mil.
Ortin Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-36.34 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Ortin Laboratories's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=206.038/-34.215
=-6.02

Ortin Laboratories's current Enterprise Value is ₹206.04 Mil.
Ortin Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-34.22 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Ortin Laboratories's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=206.038/34.232
=6.02

Ortin Laboratories's current Enterprise Value is ₹206.04 Mil.
Ortin Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹34.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ortin Laboratories Enterprise Value Related Terms

Thank you for viewing the detailed overview of Ortin Laboratories's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortin Laboratories (BOM:539287) Business Description

Traded in Other Exchanges
Address
Street no. 3, D. No. 1-8-B4, Ground Floor,Block-4, F3 HIG, Baghlingampally, Hyderabad, TG, IND, 500 044
Ortin Laboratories Ltd is an India based engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its APIs Intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others.It earns key revenue from domestic sales.

Ortin Laboratories (BOM:539287) Headlines

No Headlines